These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2088363)

  • 1. Aspects of the medicinal chemistry of fluoroorganic compounds. Part II.
    Resnati G
    Farmaco; 1990 Nov; 45(11):1137-67. PubMed ID: 2088363
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspects of the medicinal chemistry of fluoroorganic compounds. Part I.
    Resnati G
    Farmaco; 1990 Oct; 45(10):1043-66. PubMed ID: 2095151
    [No Abstract]   [Full Text] [Related]  

  • 3. Fluorine in medicinal chemistry.
    Purser S; Moore PR; Swallow S; Gouverneur V
    Chem Soc Rev; 2008 Feb; 37(2):320-30. PubMed ID: 18197348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II-III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas.
    Zhou Y; Wang J; Gu Z; Wang S; Zhu W; Aceña JL; Soloshonok VA; Izawa K; Liu H
    Chem Rev; 2016 Jan; 116(2):422-518. PubMed ID: 26756377
    [No Abstract]   [Full Text] [Related]  

  • 5. Trifluoromethyl ethers and -thioethers as tools for medicinal chemistry and drug discovery.
    Landelle G; Panossian A; Leroux FR
    Curr Top Med Chem; 2014; 14(7):941-51. PubMed ID: 24484423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorinated mechanism-based inhibitors: common themes and recent developments.
    Tysoe C; Withers SG
    Curr Top Med Chem; 2014; 14(7):865-74. PubMed ID: 24484426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Editorial: Fluorination and fluorinated compounds in medicinal chemistry.
    Altman RA
    Curr Top Med Chem; 2014; 14(7):837-9. PubMed ID: 24484420
    [No Abstract]   [Full Text] [Related]  

  • 8. New fluoro-diphenylchalcogen derivatives to explore the serotonin transporter by PET.
    Vercouillie J; Deuther-Conrad W; Scheunemann M; Emond P; Fischer S; Funke U; Steinbach J; Guilloteau D; Brust P
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4991-5. PubMed ID: 17658253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trifluoromethylated heterocycles.
    Gakh AA; Shermolovich Y
    Curr Top Med Chem; 2014; 14(7):952-65. PubMed ID: 24484422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Special applications of fluorinated organic compounds.
    Lewandowski G; Meissner E; Milchert E
    J Hazard Mater; 2006 Aug; 136(3):385-91. PubMed ID: 16759798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. alpha-fluorinated ethers as "exotic" entity in medicinal chemistry.
    Jeschke P; Baston E; Leroux FR
    Mini Rev Med Chem; 2007 Oct; 7(10):1027-34. PubMed ID: 17979805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleophilic fluoroalkylation of epoxides with fluorinated sulfones.
    Ni C; Li Y; Hu J
    J Org Chem; 2006 Sep; 71(18):6829-33. PubMed ID: 16930033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-fluorinated ethers, thioethers, and amines: anomerically biased species.
    Leroux F; Jeschke P; Schlosser M
    Chem Rev; 2005 Mar; 105(3):827-56. PubMed ID: 15755078
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclopropane fatty acid synthase from Escherichia coli: enzyme purification and inhibition by vinylfluorine and epoxide-containing substrate analogues.
    Molitor EJ; Paschal BM; Liu HW
    Chembiochem; 2003 Dec; 4(12):1352-6. PubMed ID: 14661280
    [No Abstract]   [Full Text] [Related]  

  • 15. What is so special about the sorption behavior of highly fluorinated compounds?
    Goss KU; Bronner G
    J Phys Chem A; 2006 Aug; 110(30):9518-22. PubMed ID: 16869704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New routes to organofluorine compounds based on ketenes and the radical transfer of xanthates.
    Zard SZ
    Org Biomol Chem; 2007 Jan; 5(2):205-13. PubMed ID: 17205160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using hydrofluoroether solvents to replace HCFC-141b, Part II.
    Govaerts F; Keane DD
    Med Device Technol; 2001 Nov; 12(9):28-30. PubMed ID: 12938535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of the transactivation activity of phenylpropanoic acid-type peroxisome proliferator-activated receptor pan agonists: effect of introduction of fluorine at the linker part.
    Kasuga J; Oyama T; Hirakawa Y; Makishima M; Morikawa K; Hashimoto Y; Miyachi H
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4525-8. PubMed ID: 18662876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-(2,2,2-Trifluoroethylidene)-1,3-dithiane monoxide as a trifluoromethylketene equivalent.
    Yoshida S; Yorimitsu H; Oshima K
    Org Lett; 2009 May; 11(10):2185-8. PubMed ID: 19371075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermolysis of fluorinated cycloalkylidene fulgides yields a new class of photochromic compounds.
    Wolak MA; Gillespie NB; Birge RR; Lees WJ
    Chem Commun (Camb); 2003 Apr; (8):992-3. PubMed ID: 12744335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.